Mobia Medical, Inc. Common Stock (MOBI) - Net Assets
Based on the latest financial reports, Mobia Medical, Inc. Common Stock (MOBI) has net assets worth $-167.75 Million USD as of March 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($73.60 Million) and total liabilities ($241.34 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Also explore MOBI current and non-current assets for the complete picture of this company's asset base.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $-167.75 Million |
| % of Total Assets | -227.93% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
Mobia Medical, Inc. Common Stock - Net Assets Trend (2024–2025)
This chart illustrates how Mobia Medical, Inc. Common Stock's net assets have evolved over time, based on quarterly financial data. Also explore Mobia Medical, Inc. Common Stock (MOBI) net asset momentum to track the company's year-over-year net asset growth rate.
Annual Net Assets for Mobia Medical, Inc. Common Stock (2024–2025)
The table below shows the annual net assets of Mobia Medical, Inc. Common Stock from 2024 to 2025. For live valuation and market cap data, see market cap of Mobia Medical, Inc. Common Stock.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | $-150.77 Million | -42.19% |
| 2024-12-31 | $-106.04 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Mobia Medical, Inc. Common Stock's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 4649818800.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $8.84K | % |
| Other Components | $7.01 Million | % |
| Total Equity | $-150.77 Million | 100.00% |
Mobia Medical, Inc. Common Stock Competitors by Market Cap
The table below lists competitors of Mobia Medical, Inc. Common Stock ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Bumble Inc
NASDAQ:BMBL
|
$371.73 Million |
|
Ege Endustri ve Ticaret AS
IS:EGEEN
|
$371.81 Million |
|
Shanghai Information2 Software Inc. A
SHG:688435
|
$371.81 Million |
|
Beijing HuaYuanYiTong Thermal Technology Co Ltd
SHE:002893
|
$371.90 Million |
|
KoMiCo Ltd
KQ:183300
|
$371.66 Million |
|
Chongqing Mas Sci&Tech
SHE:300275
|
$371.38 Million |
|
Golden Eagle Energy Tbk
JK:SMMT
|
$371.28 Million |
|
Anhui Fengyuan Pharmaceutical Co Ltd
SHE:000153
|
$371.27 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Mobia Medical, Inc. Common Stock's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from -106,035,803 to -150,773,587, a change of -44,737,784.
- Net loss of 46,498,188 reduced equity.
- New share issuances of 64,712,687 increased equity.
- Other factors decreased equity by 62,952,283.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-46.50 Million | -30.84% |
| Share Issuances | $64.71 Million | +42.92% |
| Other Changes | $-62.95 Million | -41.75% |
| Total Change | $- | % |
Book Value vs Market Value Analysis
This analysis compares Mobia Medical, Inc. Common Stock's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2024-12-31 | $-3.20 | $11.18 | x |
| 2025-12-31 | $-4.56 | $11.18 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Mobia Medical, Inc. Common Stock utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 0.00%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -145.12%
- • Asset Turnover: 0.67x
- • Equity Multiplier: 0.00x
- Recent ROE (0.00%) is below the historical average (0.00%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2024 | 0.00% | -157.26% | 0.71x | 0.00x | $-14.00 Million |
| 2025 | 0.00% | -145.12% | 0.67x | 0.00x | $-31.42 Million |
Industry Comparison
This section compares Mobia Medical, Inc. Common Stock's net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $411,255,254
- Average return on equity (ROE) among peers: -85.10%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Mobia Medical, Inc. Common Stock (MOBI) | $-167.75 Million | 0.00% | N/A | $371.72 Million |
| Abbott Laboratories (ABT) | $3.67 Billion | 38.07% | 1.09x | $183.80 Billion |
| Adagio Medical Holdings, Inc Common Stock (ADGM) | $-72.62 Million | 0.00% | 0.00x | $8.40 Million |
| Aethlon Medical Inc (AEMD) | $1.50 Million | -324.29% | 0.70x | $867.97K |
| Acutus Medical Inc (AFIB) | $126.58 Million | -80.56% | 0.52x | $903.35K |
| Adapthealth Corp (AHCO) | $280.85 Million | -57.55% | 5.46x | $1.39 Billion |
| 20/20 Biolabs, Inc. Common Stock (AIDX) | $2.15 Million | -112.84% | 0.45x | $4.45 Million |
| Allurion Technologies, Inc. (ALUR) | $-34.28 Million | 0.00% | 0.00x | $13.77 Million |
| Autonomix Medical, Inc. Common Stock (AMIX) | $5.89 Million | -283.55% | 0.29x | $1.87 Million |
| Artivion Inc (AORT) | $121.54 Million | 6.06% | 0.22x | $1.16 Billion |
| Apyx Medical Inc (APYX) | $6.01 Million | -36.31% | 0.22x | $171.68 Million |
About Mobia Medical, Inc. Common Stock
Mobia Medical, Inc. develops and commercializes neurostimulation medical devices, including implantable systems for stroke rehabilitation and other neurological conditions. The company provides neurostimulation systems and devices that combine vagus nerve stimulation with therapy to address chronic neurological conditions. Its main product, the Vivistim System, is an FDA-approved implantable devi… Read more